Catalent (CTLT) Reports In-Line Q2 EPS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/13/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Super Micro Computer establishes $1.25 billion stock sale agreement
- Wall Street ends higher as SpaceX's market debut dominates
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- SpaceX Shares Indicated To Open At $155
Catalent, Inc. Reports Second Quarter Fiscal Year 2017 Results
February 6, 2017 4:15 PM ESTQ2'17 revenue $483.7 million increased 6% as-reported, or 10% in constant currency from the prior year period. Q2'17 YTD revenue $925.9 million increased 5% as-reported, or 9% in constant currency from the prior year period. Announced the acquisition of Accucaps, a Canadian developer and manufacturer of over-the-counter (OTC) and prescription softgel products. Issued 380 million, 4.75% coupon, Euro notes with proceeds used to pay down debt and fund acquisitions; simultaneous re-price of our USD (50 bps rate reduction) and EUR (75 bps rate reduction) Term Loans.... More
